Click here to go to the previous page
Meta-collaborations: A Call to Action
Program Code:
208
Date:
Tuesday, June 26, 2012
Time:
8:00 AM to 9:30 AM
EST
CHAIR
(S):
Craig Lipset is Head of Clinical Innovation, Development Operations, Worldwide Research & Development at Pfizer. Craig is working across units and stakeholders to define Pfizer’s vision for the future of clinical trials, and enabling the initiatives and investments to create that future.
|
Executive Vice President, Chief Medical Officer since December 2010. Senior Vice President, Chief Medical Officer from May 2009 until December 2010. Previously, she was Chief Medical Officer and Executive Vice President, Medicines Development at Vertex Pharmaceuticals from June 2008 until May 2009.
|
PRESENTER
(S):
Susan McCune, FDA
Margaret Anderson, FasterCures, United States
Kathy Hudson, National Institutes of Health, United States
Peter Adamson,
The Children's Hospital of Philadelphia, United States
Peter C. Adamson, MD is Chair of the Children’s Oncology Group (COG), Professor of Pediatrics & Pharmacology at University of Pennsylvania School of Medicine, and Chief of the Division of Clinical Pharmacology & Therapeutics at The Children’s Hospital of Philadelphia.
|
Executive Vice President, Chief Medical Officer since December 2010. Senior Vice President, Chief Medical Officer from May 2009 until December 2010. Previously, she was Chief Medical Officer and Executive Vice President, Medicines Development at Vertex Pharmaceuticals from June 2008 until May 2009.
|
Description
What are the barriers that are keeping ideas from turning into action, and how can these barriers be broken to develop new models for innovation and collaboration? High-level thought leaders will address these questions and discuss how industry, academia, government, and patients, through meta-collaborations, can take drug discovery to the next level by creating opportunities for moving forward and coming up with solutions faster.
Learning Objectives:
Describe how barriers can be broken to develop new models for innovation and collaboration
Discuss how collaboration can take drug discovery forward.